The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease

Abstract Background Autologous mesenchymal stem cells (MSCs) have emerged as a therapeutic option for many diseases. Hypertensive kidney disease (HKD) might impair MSCs’ reparative ability by altering the biomolecular properties, but the characteristics of this impairment are unclear. In our previou...

Full description

Bibliographic Details

Published in:	Stem Cell Research & Therapy
Main Authors:	Gurparneet Kaur Sohi, Naba Farooqui, Arjunmohan Mohan, Kamalnath Sankaran Rajagopalan, Li Xing, Xiang Y. Zhu, Kyra Jordan, James D. Krier, Ishran M. Saadiq, Hui Tang, LaTonya J. Hickson, Alfonso Eirin, Lilach O. Lerman, Sandra M. Herrmann
Format:	Article
Language:	English
Published:	BMC 2024-06-01
Subjects:	Hypertensive kidney disease Adipose mesenchymal stem cells Hypoxia preconditioning Angiogenesis Senescence
Online Access:	https://doi.org/10.1186/s13287-024-03778-1